- Home
- CLPS vs XCUR Comparison
CLPS vs XCUR Comparison
Compare CLPS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- XCUR
- Stock Information
- Founded
- CLPS 2005
- XCUR 2011
- Country
- CLPS Hong Kong
- XCUR United States
- Employees
- CLPS N/A
- XCUR N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- XCUR Health Care
- Exchange
- CLPS Nasdaq
- XCUR Nasdaq
- Market Cap
- CLPS 29.7M
- XCUR 32.4M
- IPO Year
- CLPS 2018
- XCUR N/A
- Fundamental
- Price
- CLPS $1.23
- XCUR $4.63
- Analyst Decision
- CLPS
- XCUR
- Analyst Count
- CLPS 0
- XCUR 0
- Target Price
- CLPS N/A
- XCUR N/A
- AVG Volume (30 Days)
- CLPS 89.0K
- XCUR 40.4K
- Earning Date
- CLPS 10-17-2025
- XCUR 11-13-2025
- Dividend Yield
- CLPS 10.66%
- XCUR N/A
- EPS Growth
- CLPS N/A
- XCUR N/A
- EPS
- CLPS N/A
- XCUR N/A
- Revenue
- CLPS $153,816,045.00
- XCUR N/A
- Revenue This Year
- CLPS N/A
- XCUR N/A
- Revenue Next Year
- CLPS N/A
- XCUR N/A
- P/E Ratio
- CLPS N/A
- XCUR N/A
- Revenue Growth
- CLPS 5.81
- XCUR N/A
- 52 Week Low
- CLPS $0.80
- XCUR $2.33
- 52 Week High
- CLPS $1.88
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- CLPS 56.36
- XCUR 48.77
- Support Level
- CLPS $0.98
- XCUR $4.78
- Resistance Level
- CLPS $1.88
- XCUR $5.52
- Average True Range (ATR)
- CLPS 0.11
- XCUR 0.49
- MACD
- CLPS 0.04
- XCUR 0.11
- Stochastic Oscillator
- CLPS 29.19
- XCUR 37.43
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.